KLRA Kailera Therapeutics, Inc.
Company Analysis
Latest News
🔴 Kailera Therapeutics is trading 4.8% down
Kailera Therapeutics is trading 4.8% lower at $10.87; no verified source links the decline to a specific catalyst. - The move follows a 3.91% gain on...
🟢 Kailera Therapeutics Surges 4.1% on Completion of Phase 3 Enrollment for Obesity Drug
Kailera Therapeutics is trading at $11.44, up 4.1%, following a significant company announcement. * On September 30, the company announced the completion of...
🟢 Kailera Therapeutics is trading 5% up in pre-market — no clear catalyst identified
Kailera Therapeutics is trading at $11.73, up 5.46%, with no clear company-specific announcement identified to explain its September 29 pre-market rise. - Its...
🔴 Kailera Therapeutics is trading 4.47% down today
Kailera Therapeutics is trading 4.47% lower at $11.45; the catalyst remains unconfirmed. - The shares fell from the September 24 close of $11.98. - No new...
🔴 Kailera Therapeutics is trading 10.2% down today amid broader biotech weakness
Kailera Therapeutics is trading at $11.79, down -10.21%, amid broader biotech weakness and pressure on growth-oriented valuations. - No company-specific...
🔴 Kailera Therapeutics is trading 6.2% down today as Treasury yields and oil prices pressure stocks
Kailera Therapeutics is trading 6.2% lower at $12.32 amid broad biotech and growth-stock pressure. - Rising Treasury yields and higher oil prices are...
🟢 Kailera Therapeutics is trading 6.3% up today with no verified company-specific catalyst identified
Kailera Therapeutics is trading 6.3% up at $12.74, with no verified company-specific catalyst identified for September 22, 2026. - The latest company...
🟢 Kailera Therapeutics is trading 4.08% up in pre-market with no verified company-specific catalyst identified
Kailera Therapeutics is trading 4.08% up at $12.48, with no verified company-specific catalyst identified. - Shares declined 6.55% during the September 21,...
🟢 Kailera Therapeutics is trading 4.59% up in after-hours trading following a 6.55% regular-session decline
Kailera Therapeutics is trading 4.59% up now at $12.54 after closing September 21, 2026 at $11.99, following a 6.55% regular-session decline. - No verified...
🔴 Kailera Therapeutics is trading 4.3% down today with no clear catalyst
Kailera Therapeutics is trading 4.3% down now at $12.29, reversing its reported pre-market gain with no clear catalyst identified. - No company-specific...
🟢 Kailera Therapeutics is trading 5% up in pre-market amid broader risk-on sentiment
Kailera Therapeutics is trading 4.99% up at $13.47, with the move appearing aligned with broader risk-on sentiment; no fresh company-specific announcement was...
🔴 Kailera Therapeutics is trading 4.24% down today as biotech sector falls 2.11%
Kailera Therapeutics is trading 4.24% down at $12.88, amid biotech-sector weakness. - From the September 15 close of $13.45, with no clear company-specific...
🟢 Kailera Therapeutics is trading 4.09% up today in after-hours trading — no clear catalyst identified
Kailera Therapeutics is trading 4.09% up now at $14.00 after rising from the September 15 regular-session close of $13.45, with no clear company-specific...
🔴 Kailera Therapeutics is trading 4.23% down today — no clear catalyst identified
Kailera Therapeutics is trading 4.23% down now at $14.28 despite broad market gains on September 11, 2026, with no fresh company-specific announcement or...
🔴 Kailera Therapeutics is trading 4.35% down today as oil prices rise and U.S.-Iran tensions escalate
Kailera Therapeutics is trading 4.35% down at $15.71 amid a weaker market backdrop and broader risk-off sentiment driven by rising oil prices and escalating...
Frazier Life Sciences Buys $24M Kailera Stake, Targeting GLP-1 Obesity Market
Frazier Life Sciences Management L.P. established a new position in Kailera Therapeutics, Inc. by acquiring 1,100,000 shares. The stake is valued at...
Atlas Venture Buys $113.9M Kailera Stake, Its Fourth-Largest Holding
Atlas Venture Life Science Advisors LLC disclosed a new position in Kailera Therapeutics, Inc. via a recent 13F filing. The firm acquired 5,171,282 shares...
🟢 Kailera Therapeutics is trading 4.35% up today with no verified catalyst identified
Kailera Therapeutics is trading 4.35% up at $16.43, with no verified company-specific announcement identified for September 4, 2026. - Latest confirmed...
🟢 Kailera Therapeutics is trading 4.1% up in pre-market
Kailera Therapeutics is trading 4.1% up at $16.50 after closing at $15.85 on September 2, 2026, with no verified company-specific catalyst identified. - No...
🔴 Kailera Therapeutics is trading 4.78% down today after reversing its September 1 gain
Kailera Therapeutics is trading 4.78% down at $15.62 after reversing its September 1 gain of 6.56%. - No verified September 2 company-specific announcement,...